Increased mitochondrial calcium levels associated with neuronal death in a mouse model of Alzheimer's disease.
basic_science · Level V
Where this comes from
- Record sourced from PubMed, PMID 32358564.
- Also identified by DOI 10.1038/s41467-020-16074-2 and PMC identifier 7195480.
- Licence recorded as CC BY.
- The licence permits redistribution, so the abstract is shown in full and the full text is available from the publisher.
Abstract
Mitochondria contribute to shape intraneuronal Ca<sup>2+</sup> signals. Excessive Ca<sup>2+</sup> taken up by mitochondria could lead to cell death. Amyloid beta (Aβ) causes cytosolic Ca<sup>2+</sup> overload, but the effects of Aβ on mitochondrial Ca<sup>2+</sup> levels in Alzheimer's disease (AD) remain unclear. Using a ratiometric Ca<sup>2+</sup> indicator targeted to neuronal mitochondria and intravital multiphoton microscopy, we find increased mitochondrial Ca<sup>2+</sup> levels associated with plaque deposition and neuronal death in a transgenic mouse model of cerebral β-amyloidosis. Naturally secreted soluble Aβ applied onto the healthy brain increases Ca<sup>2+</sup> concentration in mitochondria, which is prevented by blockage of the mitochondrial calcium uniporter. RNA-sequencing from post-mortem AD human brains shows downregulation in the expression of mitochondrial influx Ca<sup>2+</sup> transporter genes, but upregulation in the genes related to mitochondrial Ca<sup>2+</sup> efflux pathways, suggesting a counteracting effect to avoid Ca<sup>2+</sup> overload. We propose lowering neuronal mitochondrial Ca<sup>2+</sup> by inhibiting the mitochondrial Ca<sup>2+</sup> uniporter as a novel potential therapeutic target against AD.
Medical subject headings
- Alzheimer Disease
- Brain
- Calcium
- Mitochondria
- Neurodegenerative Diseases
- Neurons